Latest On Zymeworks Inc (ZYME):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 13:02 EST | News | Zymeworks COO to step down | N/A |  |
| 2023-05-09 06:05 EST | News | Zymeworks Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-09 06:05 EST | News | Zymeworks Inc. (ZYME) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-08 17:21 EST | News | Zymeworks Non-GAAP EPS of -$0.34 beats by $0.20, revenue of $35.58M beats by $16.06M | N/A | |
| 2023-05-08 17:21 EST | News | Zymeworks GAAP EPS of -$0.37 beats by $0.12, revenue of $35.58M beats by $16.06M | N/A | |
| 2023-05-08 04:16 EST | News | Zymeworks Q1 2023 Earnings Preview | N/A | |
| 2023-04-10 14:26 EST | News | Zymeworks: Exciting Short Squeeze Candidate With Large Cash Holdings | N/A | |
| 2023-03-21 12:15 EST | News | Zymeworks a buy at Wells Fargo on royalty streams, future milestones | N/A | |
| 2023-03-20 21:19 EST | News | Zymeworks and Daiichi Sankyo end bispecific antibody deal | N/A | |
| 2023-03-08 18:10 EST | News | Zymeworks gains 11% on Q4 earnings beat; provides update on cancer drug | N/A | |
| 2023-03-08 02:40 EST | News | Zymeworks GAAP EPS of $4.65 beats by $2.16, revenue of $402.49M beats by $188.16M | N/A | |
| 2023-03-08 02:40 EST | News | Zymeworks Inc. 2022 Q4 - Results - Earnings Call Presentation | N/A | |
| 2023-03-08 02:40 EST | News | Zymeworks Inc. (ZYME) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-06 21:19 EST | News | Zymeworks Q4 2022 Earnings Preview | N/A | |
| 2023-02-23 08:04 EST | News | Zymeworks: Completion Of Jazz Deal Provides New Life | N/A | |
| 2023-02-17 09:32 EST | News | Zymeworks (ZYME) presents at SVB Securities Global Biopharma Conference - Slideshow | N/A | |
| 2023-01-19 12:13 EST | News | Jazz Pharma, Zymeworks post 84% overall survival for GIT cancer candidate | N/A | |
| 2023-01-14 15:41 EST | News | Stocks To Watch: Economic Reports, Earnings Blockbusters And Political Minefields Lie Ahead Next Week | N/A | |
| 2023-01-13 15:49 EST | News | Zymeworks nears one-year high after insider purchase | N/A | |
| 2023-01-12 04:12 EST | News | Zymeworks: Good Data, Lots Of Cash, Stagnant Stock | N/A | |
| 2023-01-09 09:34 EST | News | Revisiting Zymeworks After A Big Licensing Deal | N/A | |
| 2023-01-05 01:54 EST | News | Zymeworks says cash runway will fund operations through 2026; CMO leaving biotech | N/A | |
| 2022-12-05 16:58 EST | News | Zymeworks to transfer listing to Nasdaq | N/A | |
| 2022-11-08 21:40 EST | News | Zymeworks Non-GAAP EPS of -$0.66 beats by $0.31, revenue of $2.6M misses by $1.95M | N/A | |
| 2022-11-08 21:40 EST | News | Zymeworks Inc. 2022 Q3 - Results - Earnings Call Presentation | N/A | |
| 2022-11-08 21:40 EST | News | Zymeworks Inc. (ZYME) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-08 03:06 EST | News | Zymeworks Q3 2022 Earnings Preview | N/A | |
| 2022-10-27 01:05 EST | News | Jazz Pharmaceuticals' Deal With Zymeworks Offers Good Reward-Risk Ratio | N/A | |
| 2022-10-26 08:26 EST | News | Zymeworks: A Binary Event With BTC Data By End-2022 Which May Trigger Milestone | N/A | |
| 2022-10-21 15:12 EST | News | Zymeworks downgraded at SVB citing Jazz licensing deal and clinical updates | N/A | |
| 2022-10-19 16:53 EST | News | Zymeworks surges 14% on license deal with Jazz for cancer drug zanidatamab | N/A | |
| 2022-10-04 23:29 EST | News | Zymeworks draws bullish view at Wells Fargo ahead of multiple catalysts | N/A | |
| 2022-09-06 17:29 EST | News | Zymeworks plunges 20% after Phase 1 data for cancer candidate | N/A | |
| 2022-08-07 13:53 EST | News | Zymeworks Inc. (ZYME) CEO Ken Galbraith on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-04 19:14 EST | News | Zymeworks Non-GAAP EPS of -$0.92 beats by $0.02, revenue of $5.44M misses by $0.02M | N/A | |
| 2022-08-04 03:57 EST | News | Zymeworks Q2 2022 Earnings Preview | N/A | |
| 2022-07-26 23:01 EST | News | Zymeworks: A Roller Coaster Year | N/A | |
| 2022-06-27 18:43 EST | News | Zymeworks appoints new science chief | N/A | |
| 2022-06-15 17:40 EST | News | Zymeworks (ZYME) Presents At Jefferies Healthcare Conference - Slideshow | N/A | |
| 2022-06-11 10:36 EST | News | Zymeworks adopts shareholder rights plan after All Blue Falcons proposal | N/A | |
| 2022-05-26 20:17 EST | News | Zymeworks jumps after bidder All Blue Falcons raises state, promising data ahead of ASCO conference (update) | N/A | |
| 2022-05-22 00:43 EST | News | Zymeworks rejects $10.50/share proposal from All Blue Falcons | N/A | |
| 2022-05-20 07:51 EST | News | Zymeworks soars as bidder All Blue adds oncology expert to its team | N/A | |
| 2022-05-17 20:15 EST | News | Zymeworks And The Blue Falcon Elucidation | N/A | |
| 2022-05-05 13:56 EST | News | Zymeworks GAAP EPS of -$1.19 misses by $0.33 | N/A | |
| 2022-05-05 13:55 EST | News | Zymeworks Inc. (ZYME) CEO Kenneth Galbraith on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-03 23:01 EST | News | Zymeworks buyout bid backed by former AstraZeneca oncology head | N/A | |
| 2022-05-03 23:01 EST | News | Zymeworks Q1 2022 Earnings Preview | N/A | |
| 2022-04-29 15:20 EST | News | Zymeworks $10.50/share bid likely to be rejected, white knight possible - analyst | N/A | |
| 2022-04-28 22:20 EST | News | Zymeworks jumps on $10.50/share takeover bid (update) | N/A | |
About Zymeworks Inc (ZYME):
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, and breast cancer; and ZW49, a biparatopic anti- human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; and BeiGene, Ltd. It also has licensing and research collaboration with LEO Pharma A/S to discover and develop bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was founded in 2003 and is headquartered in Vancouver, Canada.
General
- Name Zymeworks Inc
- Symbol ZYME
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 352
- Fiscal Year EndDecember
- IPO Date2017-04-28
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.zymeworks.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 46.99
- Price/Book (Most Recent Quarter) 4.09
- Enterprise Value Revenue 32.31
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$4.40
- Next Year EPS Estimate -$3.02
- Next Quarter EPS Estimate -$1.22
- Operating Margin -481%
- Return on Assets -26%
- Return on Equity -55%
- Revenue 38.95 million
- Earnings Per Share -$1.63
- Revenue Per Share $0.77
- Gross Profit -129583000
- Quarterly Earnings Growth 735.4%
View More
Highlights
- Market Capitalization 1.52 billion
- EBITDA -51618000
- PE Ratio -3.52
- Analyst Target Price $56.63
- Book Value Per Share $8.90
View More
Share Statistics
- Shares Outstanding 46.14 million
- Shares Float 39.92 million
- % Held by Insiders 985%
- % Held by Institutions 78.81%
- Shares Short 1.81 million
- Shares Short Prior Month 750971
- Short Ratio 2.59
- Short % of Float 4%
- Short % of Shares Outstanding 4%
View More
Technicals
- Beta 1.05
- 52 Week High $59.03
- 52 Week Low $25.44
- 50 Day Moving Average 37.6
- 200 Day Moving Average 43.73
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Zymeworks Inc (ZYME) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Zymeworks Inc (ZYME) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-24 | $N/A | -$0.74 | -$1.25 | 40.63% |
| 2020-09-30 | 2020-11-03 | $N/A | -$1.43 | -$0.99 | -45% |
| 2020-06-30 | 2020-08-05 | $12.36 million | -$0.77 | -$0.87 | 11.83% |
| 2020-03-31 | 2020-05-07 | $8.27 million | -$0.64 | -$1.04 | 38.67% |
| 2019-12-31 | 2020-03-02 | $1.88 million | -$1.66 | -$0.88 | -88.55% |
| 2019-09-30 | 2019-11-05 | $7.86 million | -$0.70 | -$0.74 | 5.81% |
| 2019-06-30 | 2019-08-02 | $7.88 million | -$0.86 | -$0.60 | -44.31% |
| 2019-03-31 | 2019-05-02 | $11.93 million | -$0.43 | -$0.52 | 16.86% |
| 2018-12-31 | 2019-03-06 | $28.93 million | $0.29 | $0.53 | -45.55% |
| 2018-09-30 | 2018-11-06 | $2.05 million | -$0.59 | -$0.64 | 8.43% |
| 2018-06-30 | 2018-08-01 | $22 million | -$0.22 | -$0.33 | 33.85% |
| 2018-03-31 | 2018-05-01 | $40000 | -$0.83 | -$0.67 | -23.86% |
| 2017-12-31 | 2018-03-14 | $50.07 million | $1.28 | -$0.03 | 4591.23% |
| 2017-09-30 | 2017-11-08 | $119000 | -$0.64 | -$0.57 | -12.06% |
| 2017-06-30 | 2017-08-08 | $1.34 million | -$0.38 | -$0.54 | 30.46% |
| 2017-03-31 | 2017-04-28 | $230000 | -$1.19 | -$0.60 | -99.13% |
Zymeworks Inc (ZYME) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Zymeworks Inc (ZYME) Chart:
Zymeworks Inc (ZYME) News:
Below you will find a list of latest news for Zymeworks Inc (ZYME) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Zymeworks Inc (ZYME) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-16 | 2.5 | 0 | CALL | 0 | 0 | 1082.02 | TRUE | 0 | 0 |
| 2025-05-16 | 5 | 7.8 | CALL | 0 | 0 | 616.24 | TRUE | 0 | 0 |
| 2025-05-16 | 7.5 | 0 | CALL | 0 | 0 | 355.94 | TRUE | 0 | 0 |
| 2025-05-16 | 10 | 2.6 | CALL | 0 | 0 | 297.69 | TRUE | 0 | 0 |
| 2025-05-16 | 12.5 | 1.56 | CALL | 0 | 889 | 184.55 | FALSE | 0 | 0 |
| 2025-05-16 | 15 | 0.25 | CALL | 0 | 122 | 168.15 | FALSE | 0 | 0 |
| 2025-05-16 | 17.5 | 0 | CALL | 0 | 0 | 704.37 | FALSE | 0 | 0 |
| 2025-05-16 | 20 | 0 | CALL | 0 | 0 | 772.54 | FALSE | 0 | 0 |
| 2025-05-16 | 22.5 | 0 | CALL | 0 | 0 | 829.03 | FALSE | 0 | 0 |
| 2025-05-16 | 25 | 0 | CALL | 0 | 0 | 877.18 | FALSE | 0 | 0 |
| 2025-05-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-05-16 | 5 | 0 | PUT | 0 | 0 | 1440.73 | FALSE | 0 | 0 |
| 2025-05-16 | 7.5 | 0 | PUT | 0 | 0 | 908.09 | FALSE | 0 | 0 |
| 2025-05-16 | 10 | 0 | PUT | 0 | 0 | 535.7 | FALSE | 0 | 0 |
| 2025-05-16 | 12.5 | 1.25 | PUT | 0 | 374 | 301.17 | TRUE | 0 | 0 |
| 2025-05-16 | 15 | 0 | PUT | 0 | 0 | 473.65 | TRUE | 0 | 0 |
| 2025-05-16 | 17.5 | 0 | PUT | 0 | 0 | 593.88 | TRUE | 0 | 0 |
| 2025-05-16 | 20 | 0 | PUT | 0 | 0 | 625.52 | TRUE | 0 | 0 |
| 2025-05-16 | 22.5 | 0 | PUT | 0 | 0 | 605.31 | TRUE | 0 | 0 |
| 2025-05-16 | 25 | 0 | PUT | 0 | 0 | 690.58 | TRUE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | CALL | 0 | 0 | 411.69 | TRUE | 0 | 0 |
| 2025-06-20 | 5 | 0 | CALL | 0 | 0 | 268.06 | TRUE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | CALL | 0 | 0 | 259.24 | TRUE | 0 | 0 |
| 2025-06-20 | 10 | 3.08 | CALL | 0 | 4 | 119.7 | TRUE | 0 | 0 |
| 2025-06-20 | 12.5 | 0 | CALL | 0 | 0 | 67.79 | FALSE | 0 | 0 |
| 2025-06-20 | 15 | 0.6 | CALL | 0 | 26 | 85.38 | FALSE | 0 | 0 |
| 2025-06-20 | 17.5 | 0 | CALL | 0 | 0 | 117.35 | FALSE | 0 | 0 |
| 2025-06-20 | 20 | 0 | CALL | 0 | 0 | 294.74 | FALSE | 0 | 0 |
| 2025-06-20 | 22.5 | 0 | CALL | 0 | 0 | 316.39 | FALSE | 0 | 0 |
| 2025-06-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2025-06-20 | 5 | 0 | PUT | 0 | 0 | 553.22 | FALSE | 0 | 0 |
| 2025-06-20 | 7.5 | 0 | PUT | 0 | 0 | 349.05 | FALSE | 0 | 0 |
| 2025-06-20 | 10 | 0 | PUT | 0 | 0 | 69.22 | FALSE | 0 | 0 |
| 2025-06-20 | 12.5 | 1.64 | PUT | 0 | 2 | 133.72 | TRUE | 0 | 0 |
| 2025-06-20 | 15 | 3.36 | PUT | 0 | 2 | 142.88 | TRUE | 0 | 0 |
| 2025-06-20 | 17.5 | 0 | PUT | 0 | 0 | 83.5 | TRUE | 0 | 0 |
| 2025-06-20 | 20 | 0 | PUT | 0 | 0 | 256.85 | TRUE | 0 | 0 |
| 2025-06-20 | 22.5 | 0 | PUT | 0 | 0 | 278.8 | TRUE | 0 | 0 |
| 2025-07-18 | 2.5 | 0 | CALL | 0 | 0 | 315.96 | TRUE | 0 | 0 |
| 2025-07-18 | 5 | 5.5 | CALL | 0 | 1 | 224.2 | TRUE | 0 | 0 |
| 2025-07-18 | 7.5 | 0 | CALL | 0 | 0 | 119.72 | TRUE | 0 | 0 |
| 2025-07-18 | 10 | 1.85 | CALL | 0 | 11 | 95.59 | TRUE | 0 | 0 |
| 2025-07-18 | 12.5 | 1 | CALL | 0 | 12 | 86.56 | FALSE | 0 | 0 |
| 2025-07-18 | 15 | 0.8 | CALL | 0 | 1183 | 92 | FALSE | 0 | 0 |
| 2025-07-18 | 17.5 | 0.61 | CALL | 0 | 551 | 99.08 | FALSE | 0 | 0 |
| 2025-07-18 | 20 | 0.43 | CALL | 0 | 1023 | 100.36 | FALSE | 0 | 0 |
| 2025-07-18 | 22.5 | 0.26 | CALL | 0 | 68 | 218.81 | FALSE | 0 | 0 |
| 2025-07-18 | 25 | 0.65 | CALL | 0 | 1 | 257.67 | FALSE | 0 | 0 |
| 2025-07-18 | 30 | 0 | CALL | 0 | 0 | 281 | FALSE | 0 | 0 |
| 2025-07-18 | 35 | 0 | CALL | 0 | 0 | 299.62 | FALSE | 0 | 0 |
| 2025-07-18 | 2.5 | 0 | PUT | 0 | 0 | 1233.88 | FALSE | 0 | 0 |
| 2025-07-18 | 5 | 0.62 | PUT | 0 | 3 | 427.71 | FALSE | 0 | 0 |
| 2025-07-18 | 7.5 | 0 | PUT | 0 | 0 | 270.07 | FALSE | 0 | 0 |
| 2025-07-18 | 10 | 0.5 | PUT | 0 | 25 | 82.85 | FALSE | 0 | 0 |
| 2025-07-18 | 12.5 | 3.4 | PUT | 0 | 43 | 55.24 | TRUE | 0 | 0 |
| 2025-07-18 | 15 | 4.3 | PUT | 0 | 8 | 114.46 | TRUE | 0 | 0 |
| 2025-07-18 | 17.5 | 0 | PUT | 0 | 0 | 74.21 | TRUE | 0 | 0 |
| 2025-07-18 | 20 | 0 | PUT | 0 | 0 | 194.96 | TRUE | 0 | 0 |
| 2025-07-18 | 22.5 | 0 | PUT | 0 | 0 | 217.43 | TRUE | 0 | 0 |
| 2025-07-18 | 25 | 0 | PUT | 0 | 0 | 215.98 | TRUE | 0 | 0 |
| 2025-07-18 | 30 | 0 | PUT | 0 | 0 | 256.56 | TRUE | 0 | 0 |
| 2025-07-18 | 35 | 0 | PUT | 0 | 0 | 223.46 | TRUE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | CALL | 0 | 0 | 483.43 | TRUE | 0 | 0 |
| 2025-09-19 | 5 | 0 | CALL | 0 | 0 | 159.95 | TRUE | 0 | 0 |
| 2025-09-19 | 7.5 | 0 | CALL | 0 | 0 | 127.91 | TRUE | 0 | 0 |
| 2025-09-19 | 10 | 3.7 | CALL | 0 | 0 | 96.04 | TRUE | 0 | 0 |
| 2025-09-19 | 12.5 | 2.55 | CALL | 1 | 17 | 108.74 | FALSE | 2.55 | 0 |
| 2025-09-19 | 15 | 1.95 | CALL | 1 | 777 | 111.56 | FALSE | 1.95 | 0 |
| 2025-09-19 | 17.5 | 1.7 | CALL | 0 | 55 | 86.9 | FALSE | 0 | 0 |
| 2025-09-19 | 20 | 1.45 | CALL | 0 | 17 | 92.35 | FALSE | 0 | 0 |
| 2025-09-19 | 22.5 | 1.35 | CALL | 0 | 53 | 98.11 | FALSE | 0 | 0 |
| 2025-09-19 | 25 | 0.85 | CALL | 0 | 3 | 103.02 | FALSE | 0 | 0 |
| 2025-09-19 | 30 | 0.85 | CALL | 0 | 14 | 198.74 | FALSE | 0 | 0 |
| 2025-09-19 | 2.5 | 0 | PUT | 0 | 0 | 924.04 | FALSE | 0 | 0 |
| 2025-09-19 | 5 | 0 | PUT | 0 | 0 | 301.83 | FALSE | 0 | 0 |
| 2025-09-19 | 7.5 | 0.95 | PUT | 0 | 1 | 193.98 | FALSE | 0 | 0 |
| 2025-09-19 | 10 | 2 | PUT | 0 | 43 | 93.92 | FALSE | 0 | 0 |
| 2025-09-19 | 12.5 | 3.15 | PUT | 0 | 49 | 82.72 | TRUE | 0 | 0 |
| 2025-09-19 | 15 | 4.6 | PUT | 0 | 2 | 75.39 | TRUE | 0 | 0 |
| 2025-09-19 | 17.5 | 7.7 | PUT | 0 | 3 | 89.4 | TRUE | 0 | 0 |
| 2025-09-19 | 20 | 6.7 | PUT | 0 | 1 | 116.79 | TRUE | 0 | 0 |
| 2025-09-19 | 22.5 | 9.1 | PUT | 0 | 3 | 85.08 | TRUE | 0 | 0 |
| 2025-09-19 | 25 | 0 | PUT | 0 | 0 | 94.56 | TRUE | 0 | 0 |
| 2025-09-19 | 30 | 0 | PUT | 0 | 0 | 202.01 | TRUE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | CALL | 0 | 0 | 186.69 | TRUE | 0 | 0 |
| 2025-10-17 | 5 | 0 | CALL | 0 | 0 | 140.19 | TRUE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | CALL | 0 | 0 | 131 | TRUE | 0 | 0 |
| 2025-10-17 | 10 | 0 | CALL | 0 | 0 | 120.75 | TRUE | 0 | 0 |
| 2025-10-17 | 12.5 | 3.75 | CALL | 0 | 4 | 82.19 | FALSE | 0 | 0 |
| 2025-10-17 | 15 | 2.85 | CALL | 0 | 44 | 87.46 | FALSE | 0 | 0 |
| 2025-10-17 | 17.5 | 2.05 | CALL | 0 | 3 | 86.18 | FALSE | 0 | 0 |
| 2025-10-17 | 20 | 1.9 | CALL | 0 | 23 | 97.81 | FALSE | 0 | 0 |
| 2025-10-17 | 22.5 | 1.35 | CALL | 0 | 3 | 91.2 | FALSE | 0 | 0 |
| 2025-10-17 | 25 | 0.95 | CALL | 0 | 4 | 95.88 | FALSE | 0 | 0 |
| 2025-10-17 | 30 | 0 | CALL | 0 | 0 | 176.81 | FALSE | 0 | 0 |
| 2025-10-17 | 2.5 | 0 | PUT | 0 | 0 | 853.48 | FALSE | 0 | 0 |
| 2025-10-17 | 5 | 0 | PUT | 0 | 0 | 279.21 | FALSE | 0 | 0 |
| 2025-10-17 | 7.5 | 0 | PUT | 0 | 0 | 179.47 | FALSE | 0 | 0 |
| 2025-10-17 | 10 | 2.1 | PUT | 0 | 15 | 76.24 | FALSE | 0 | 0 |
| 2025-10-17 | 12.5 | 0 | PUT | 0 | 0 | 73.32 | TRUE | 0 | 0 |
| 2025-10-17 | 15 | 5 | PUT | 0 | 2 | 85.29 | TRUE | 0 | 0 |
| 2025-10-17 | 17.5 | 0 | PUT | 0 | 0 | 100.93 | TRUE | 0 | 0 |
| 2025-10-17 | 20 | 0 | PUT | 0 | 0 | 109.3 | TRUE | 0 | 0 |
| 2025-10-17 | 22.5 | 0 | PUT | 0 | 0 | 104.86 | TRUE | 0 | 0 |
| 2025-10-17 | 25 | 0 | PUT | 0 | 0 | 79.22 | TRUE | 0 | 0 |
| 2025-10-17 | 30 | 0 | PUT | 0 | 0 | 98.8 | TRUE | 0 | 0 |
| 2025-12-19 | 2.5 | 11.5 | CALL | 0 | 1 | 156.08 | TRUE | 0 | 0 |
| 2025-12-19 | 5 | 0 | CALL | 0 | 0 | 109.55 | TRUE | 0 | 0 |
| 2025-12-19 | 7.5 | 6.4 | CALL | 0 | 2 | 116.35 | TRUE | 0 | 0 |
| 2025-12-19 | 10 | 5.2 | CALL | 0 | 5 | 98.79 | TRUE | 0 | 0 |
| 2025-12-19 | 12.5 | 4.3 | CALL | 0 | 32 | 110.48 | FALSE | 0 | 0 |
| 2025-12-19 | 15 | 3.4 | CALL | 0 | 15 | 106.83 | FALSE | 0 | 0 |
| 2025-12-19 | 17.5 | 2.55 | CALL | 0 | 32 | 99.79 | FALSE | 0 | 0 |
| 2025-12-19 | 20 | 2.05 | CALL | 0 | 37 | 104.5 | FALSE | 0 | 0 |
| 2025-12-19 | 22.5 | 1.9 | CALL | 0 | 18 | 107.74 | FALSE | 0 | 0 |
| 2025-12-19 | 25 | 1.5 | CALL | 0 | 3 | 115.51 | FALSE | 0 | 0 |
| 2025-12-19 | 30 | 0.75 | CALL | 0 | 18 | 114.35 | FALSE | 0 | 0 |
| 2025-12-19 | 2.5 | 0 | PUT | 0 | 0 | 751.03 | FALSE | 0 | 0 |
| 2025-12-19 | 5 | 0 | PUT | 0 | 0 | 241.63 | FALSE | 0 | 0 |
| 2025-12-19 | 7.5 | 0.8 | PUT | 0 | 30 | 139.84 | FALSE | 0 | 0 |
| 2025-12-19 | 10 | 2.15 | PUT | 2 | 44 | 88.51 | FALSE | 2.15 | 0 |
| 2025-12-19 | 12.5 | 5 | PUT | 0 | 3 | 108.54 | TRUE | 0 | 0 |
| 2025-12-19 | 15 | 3.7 | PUT | 0 | 1 | 96.87 | TRUE | 0 | 0 |
| 2025-12-19 | 17.5 | 0 | PUT | 0 | 0 | 89 | TRUE | 0 | 0 |
| 2025-12-19 | 20 | 9.09 | PUT | 0 | 7 | 111.56 | TRUE | 0 | 0 |
| 2025-12-19 | 22.5 | 0 | PUT | 0 | 0 | 127.73 | TRUE | 0 | 0 |
| 2025-12-19 | 25 | 0 | PUT | 0 | 0 | 101.78 | TRUE | 0 | 0 |
| 2025-12-19 | 30 | 0 | PUT | 0 | 0 | 94.12 | TRUE | 0 | 0 |
Latest ZYME Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 71 | $5.46 |
| Jun 13, 2022 7:59 PM EST | 21 | $5.46 |
| Jun 13, 2022 7:59 PM EST | 400 | $5.455 |
| Jun 13, 2022 7:59 PM EST | 400 | $5.455 |
| Jun 13, 2022 7:59 PM EST | 100 | $5.455 |
Zymeworks Inc (ZYME) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520184013/0001193125-20-184013-index.htm |
| 2019-02-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000005947819000030/0000059478-19-000030-index.htm |
| 2019-02-06 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000005947819000046/0000059478-19-000046-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000005947819000079/0000059478-19-000079-index.htm |
| 2019-05-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000005947819000176/0000059478-19-000176-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000031506620001283/0000315066-20-001283-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000963/0000899243-19-000963-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000964/0000899243-19-000964-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000966/0000899243-19-000966-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000993/0000899243-19-000993-index.htm |
| 2019-01-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000995/0000899243-19-000995-index.htm |
| 2019-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319009170/0000899243-19-009170-index.htm |
| 2019-03-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319009320/0000899243-19-009320-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012635/0000899243-19-012635-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012636/0000899243-19-012636-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012637/0000899243-19-012637-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012638/0000899243-19-012638-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012639/0000899243-19-012639-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm |
| 2019-05-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319016303/0000899243-19-016303-index.htm |
| 2019-06-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319016304/0000899243-19-016304-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019435/0000899243-19-019435-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019436/0000899243-19-019436-index.htm |
| 2019-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019437/0000899243-19-019437-index.htm |
| 2019-10-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319025828/0000899243-19-025828-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319027047/0000899243-19-027047-index.htm |
| 2019-12-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/0000899243-19-029160-index.htm |
| 2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000877/0000899243-20-000877-index.htm |
| 2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000878/0000899243-20-000878-index.htm |
| 2020-01-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000880/0000899243-20-000880-index.htm |
| 2020-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320002248/0000899243-20-002248-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320008000/0000899243-20-008000-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320008001/0000899243-20-008001-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320008004/0000899243-20-008004-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320008005/0000899243-20-008005-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320008007/0000899243-20-008007-index.htm |
| 2020-04-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm |
| 2020-04-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320010693/0000899243-20-010693-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012773/0000899243-20-012773-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012774/0000899243-20-012774-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012775/0000899243-20-012775-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012776/0000899243-20-012776-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012777/0000899243-20-012777-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320012778/0000899243-20-012778-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320018546/0000899243-20-018546-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320018549/0000899243-20-018549-index.htm |
| 2020-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000089924320030450/0000899243-20-030450-index.htm |
| 2019-08-09 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000093041319002283/0000930413-19-002283-index.htm |
| 2020-07-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000095012320006723/0000950123-20-006723-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000095014219000207/0000950142-19-000207-index.htm |
| 2019-05-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000095014219001069/0000950142-19-001069-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000095014220000385/0000950142-20-000385-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000106299319000947/0001062993-19-000947-index.htm |
| 2019-05-29 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000106299319002437/0001062993-19-002437-index.htm |
| 2020-02-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000110465920013799/0001104659-20-013799-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000110465920021760/0001104659-20-021760-index.htm |
| 2020-03-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1403752/000110465920038329/0001104659-20-038329-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000114420419007231/0001144204-19-007231-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000117266120000853/0001172661-20-000853-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000117266120000864/0001172661-20-000864-index.htm |
| 2019-01-22 | S-3/A | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1403752/000119312519014025/0001193125-19-014025-index.htm |
| 2019-03-06 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519065609/0001193125-19-065609-index.htm |
| 2019-03-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519065730/0001193125-19-065730-index.htm |
| 2019-03-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1403752/000119312519078301/0001193125-19-078301-index.htm |
| 2019-04-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519106033/0001193125-19-106033-index.htm |
| 2019-04-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519114571/0001193125-19-114571-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519129279/0001193125-19-129279-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519135165/0001193125-19-135165-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519135177/0001193125-19-135177-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519136932/0001193125-19-136932-index.htm |
| 2019-05-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519156697/0001193125-19-156697-index.htm |
| 2019-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519158184/0001193125-19-158184-index.htm |
| 2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519159541/0001193125-19-159541-index.htm |
| 2019-05-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519160991/0001193125-19-160991-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519166142/0001193125-19-166142-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519172154/0001193125-19-172154-index.htm |
| 2019-06-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519175738/0001193125-19-175738-index.htm |
| 2019-06-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519177481/0001193125-19-177481-index.htm |
| 2019-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519177515/0001193125-19-177515-index.htm |
| 2019-07-02 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000119312519187869/0001193125-19-187869-index.htm |
| 2019-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519194770/0001193125-19-194770-index.htm |
| 2019-08-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519212141/0001193125-19-212141-index.htm |
| 2019-08-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519212143/0001193125-19-212143-index.htm |
| 2019-08-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519232566/0001193125-19-232566-index.htm |
| 2019-09-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519248204/0001193125-19-248204-index.htm |
| 2019-09-20 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519250708/0001193125-19-250708-index.htm |
| 2019-09-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519258816/0001193125-19-258816-index.htm |
| 2019-10-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519268596/0001193125-19-268596-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519276192/0001193125-19-276192-index.htm |
| 2019-11-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519283417/0001193125-19-283417-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519284726/0001193125-19-284726-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519284732/0001193125-19-284732-index.htm |
| 2019-11-05 | POS AM | Post-Effective amendments for registration statement | https://www.sec.gov/Archives/edgar/data/1403752/000119312519284745/0001193125-19-284745-index.htm |
| 2019-11-05 | S-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1403752/000119312519284783/0001193125-19-284783-index.htm |
| 2019-11-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312519284825/0001193125-19-284825-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519286057/0001193125-19-286057-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519294661/0001193125-19-294661-index.htm |
| 2019-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312519298517/0001193125-19-298517-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520003014/0001193125-20-003014-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520006089/0001193125-20-006089-index.htm |
| 2020-01-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312520011153/0001193125-20-011153-index.htm |
| 2020-01-24 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1403752/000119312520013367/0001193125-20-013367-index.htm |
| 2020-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520013371/0001193125-20-013371-index.htm |
| 2020-01-27 | 424B8 | Prospectus filed pursuant to Rule 424(b)(8) | https://www.sec.gov/Archives/edgar/data/1403752/000119312520014620/0001193125-20-014620-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520015391/0001193125-20-015391-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000119312520038538/0001193125-20-038538-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520046466/0001193125-20-046466-index.htm |
| 2020-03-02 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1403752/000119312520058902/0001193125-20-058902-index.htm |
| 2020-03-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520058930/0001193125-20-058930-index.htm |
| 2020-03-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520073718/0001193125-20-073718-index.htm |
| 2020-03-23 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1403752/000119312520082593/0001193125-20-082593-index.htm |
| 2020-04-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520094661/0001193125-20-094661-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520137639/0001193125-20-137639-index.htm |
| 2020-05-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520154249/0001193125-20-154249-index.htm |
| 2020-06-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520184013/0001193125-20-184013-index.htm |
| 2020-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520189706/0001193125-20-189706-index.htm |
| 2020-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520189854/0001193125-20-189854-index.htm |
| 2020-09-03 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000119312520239038/0001193125-20-239038-index.htm |
| 2020-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2019-01-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000035/0001341004-19-000035-index.htm |
| 2019-01-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000052/0001341004-19-000052-index.htm |
| 2019-01-30 | DEL AM | Delaying amendment | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000055/0001341004-19-000055-index.htm |
| 2019-01-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000057/0001341004-19-000057-index.htm |
| 2019-02-15 | F-10POS | Post-effective amendment to a F-10EF registration | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000125/0001341004-19-000125-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000165/0001341004-19-000165-index.htm |
| 2019-04-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000289/0001341004-19-000289-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000356/0001341004-19-000356-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000364/0001341004-19-000364-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000134100419000417/0001341004-19-000417-index.htm |
| 2020-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000004/0001403752-20-000004-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000006/0001403752-20-000006-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000012/0001403752-20-000012-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000014/0001403752-20-000014-index.htm |
| 2020-11-03 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000020/0001403752-20-000020-index.htm |
| 2020-11-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1403752/000140375220000022/0001403752-20-000022-index.htm |
| 2020-03-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000163859920000302/0001638599-20-000302-index.htm |
| 2020-03-16 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000163859920000303/0001638599-20-000303-index.htm |
| 2020-03-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000163859920000304/0001638599-20-000304-index.htm |
| 2020-05-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1403752/000163859920000460/0001638599-20-000460-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1403752/000165495420001571/0001654954-20-001571-index.htm |
| 2019-01-31 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1403752/999999999519000046/9999999995-19-000046-index.htm |
| 2019-11-07 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1403752/999999999519002513/9999999995-19-002513-index.htm |
| 2019-04-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999719002845/9999999997-19-002845-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000304/9999999997-20-000304-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000305/9999999997-20-000305-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000307/9999999997-20-000307-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000308/9999999997-20-000308-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000309/9999999997-20-000309-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000310/9999999997-20-000310-index.htm |
| 2020-01-28 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1403752/999999999720000312/9999999997-20-000312-index.htm |
Zymeworks Inc (ZYME) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zymeworks Inc (ZYME). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 985%Institutional Ownership: 7881%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-06 | David Kai Yuen Poon | Officer | Sell | 800.00 | 19.20 | 15,360.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm |
| 2019-07-08 | Anthony J. Polverino | Chief Scientific Officer | Buy | 1,120.00 | 12.49 | 13,988.80 | 1,120.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019436/0000899243-19-019436-index.htm |
| 2019-01-08 | Neil A Klompas | Chief Financial Officer | Buy | 414.00 | 12.48 | 5,166.72 | 1,201.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000993/0000899243-19-000993-index.htm |
| 2019-05-06 | Neil A Klompas | Chief Financial Officer | Sell | 6,704.00 | 19.22 | 128,854.90 | 1,201.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm |
| 2020-09-14 | DIANA HAUSMAN | Chief Medical Officer | Buy | 10,000.00 | 15.74 | 157,400.00 | 13,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2020-09-14 | DIANA HAUSMAN | Chief Medical Officer | Buy | 10,000.00 | 17.15 | 171,500.00 | 23,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2019-01-08 | DIANA HAUSMAN | Chief Medical Officer | Buy | 499.00 | 12.48 | 6,227.52 | 2,499.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319000995/0000899243-19-000995-index.htm |
| 2020-04-13 | Ali Tehrani | Chief Executive Officer | Buy | 1,000.00 | 3.85 | 3,853.50 | 257,009.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320010693/0000899243-20-010693-index.htm |
| 2019-12-12 | Anthony J. Polverino | Chief Scientific Officer | Buy | 27,500.00 | 15.00 | 412,500.00 | 28,620.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319029160/0000899243-19-029160-index.htm |
| 2019-01-31 | ELI & CO LILLY | 10% Share Holder | Sell | 250,000.00 | 16.00 | 4,000,000.00 | 2,898,647.00 | https://www.sec.gov/Archives/edgar/data/1403752/000005947819000030/0000059478-19-000030-index.htm |
| 2020-01-08 | Anthony J. Polverino | Chief Scientific Officer | Buy | 371.00 | 19.54 | 7,249.34 | 28,991.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000880/0000899243-20-000880-index.htm |
| 2020-07-02 | Anthony J. Polverino | Chief Scientific Officer | Buy | 488.00 | 30.66 | 14,962.08 | 29,479.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320018549/0000899243-20-018549-index.htm |
| 2019-07-08 | DIANA HAUSMAN | Chief Medical Officer | Buy | 520.00 | 12.49 | 6,494.80 | 3,019.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019437/0000899243-19-019437-index.htm |
| 2020-01-08 | DIANA HAUSMAN | Chief Medical Officer | Buy | 332.00 | 19.54 | 6,487.28 | 3,351.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000878/0000899243-20-000878-index.htm |
| 2020-09-14 | DIANA HAUSMAN | Chief Medical Officer | Buy | 10,000.00 | 9.82 | 98,200.00 | 33,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2020-07-02 | DIANA HAUSMAN | Chief Medical Officer | Buy | 367.00 | 30.66 | 11,252.22 | 3,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000095012320006723/0000950123-20-006723-index.htm |
| 2020-09-14 | DIANA HAUSMAN | Chief Medical Officer | Sell | 40,000.00 | 45.00 | 1,800,000.00 | 3,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2020-09-14 | DIANA HAUSMAN | Chief Medical Officer | Buy | 10,000.00 | 11.84 | 118,400.00 | 43,718.00 | https://www.sec.gov/Archives/edgar/data/1403752/000120919120050723/0001209191-20-050723-index.htm |
| 2020-11-02 | Ali Tehrani | Chief Executive Officer | Sell | 3,500.00 | 39.04 | 136,623.90 | 56,361.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320030450/0000899243-20-030450-index.htm |
| 2019-03-29 | Ali Tehrani | Chief Executive Officer | Sell | 3,000.00 | 16.24 | 48,720.00 | 59,286.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319009320/0000899243-19-009320-index.htm |
| 2020-04-03 | Ali Tehrani | Chief Executive Officer | Buy | 495.00 | 33.39 | 16,528.20 | 59,781.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm |
| 2020-04-03 | Ali Tehrani | Chief Executive Officer | Buy | 80.00 | 33.39 | 2,671.19 | 59,861.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320010456/0000899243-20-010456-index.htm |
| 2020-01-27 | Troy Cox | Director | Buy | 7,500.00 | 46.50 | 348,750.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320002248/0000899243-20-002248-index.htm |
| 2019-05-06 | Neil A Klompas | Chief Financial Officer | Buy | 6,704.00 | 2.66 | 17,832.64 | 7,905.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm |
| 2019-05-06 | Neil A Klompas | Chief Financial Officer | Sell | 1,604.00 | 19.25 | 30,877.96 | 7,977.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm |
| 2019-05-06 | David Kai Yuen Poon | Officer | Buy | 800.00 | 3.53 | 2,824.00 | 800.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012641/0000899243-19-012641-index.htm |
| 2019-07-08 | Neil A Klompas | Chief Financial Officer | Buy | 464.00 | 12.49 | 5,795.36 | 8,441.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319019435/0000899243-19-019435-index.htm |
| 2020-01-08 | Neil A Klompas | Chief Financial Officer | Buy | 394.00 | 19.54 | 7,698.76 | 8,835.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320000877/0000899243-20-000877-index.htm |
| 2020-07-02 | Neil A Klompas | Chief Financial Officer | Buy | 277.00 | 30.66 | 8,492.82 | 9,112.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924320018546/0000899243-20-018546-index.htm |
| 2019-05-06 | Neil A Klompas | Chief Financial Officer | Buy | 8,380.00 | 3.53 | 29,581.40 | 9,581.00 | https://www.sec.gov/Archives/edgar/data/1403752/000089924319012640/0000899243-19-012640-index.htm |